secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0000721371-24-000026
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health OptumRx contracts not renewed; reaffirms FY2024 non-GAAP EPS guidance $7.20-$7.35
--------------------------------------------------------------------------------

- OptumRx contracts expire June 2024; not renewed; 16% of FY2023 consolidated revenue.
- About 90% of these sales were non-specialty bulk shipments with meaningfully lower operating margin.
- Reiterates long-term segment profit CAGR 4-6% and non-GAAP EPS CAGR 12-14% (FY2024-2026 vs FY2023).
- Expects FY2025 growth in Pharmaceutical & Specialty segment profit and non-GAAP EPS, partially offsetting impact.
- Adjusted free cash flow target ~$2B average FY2024-2026, but lower in FY2025 due to working capital unwinding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000026/0000721371-24-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000026/cah-20240422.htm
  HTML page:      https://secwatch.observer/filing/0000721371-24-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer